Feedback / Questions
risvodetinib (IkT-148009) - Inhibikase, Clintrex, ABLi Therapeutics
https://www.globenewswire.com/news-release/2025/05/12/3079103/0/en/ABLi-Therapeutics-Launches-with-a-Focus-on-Developing-Treatments-for-Neurodegenerative-Diseases-that-Arise-from-Activation-of-c-Abl-Kinases.html
May 12, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next